Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
出版年份 2020 全文链接
标题
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-12-24
DOI
10.1038/s41598-020-79598-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood–brain barrier dysfunction module
- (2019) Roeben Nocon Munji et al. NATURE NEUROSCIENCE
- Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice
- (2018) Manuel Zeitelhofer et al. PLoS One
- A molecular atlas of cell types and zonation in the brain vasculature
- (2018) Michael Vanlandewijck et al. NATURE
- Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
- (2018) Hong Li et al. PLoS One
- The EPAC–Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability
- (2017) Carla J. Ramos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
- (2017) Pei-Ran Ho et al. LANCET NEUROLOGY
- Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
- (2016) N. Wahlgren et al. JOURNAL OF INTERNAL MEDICINE
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Pharmacological targeting of the PDGF-CC signaling pathway for blood–brain barrier restoration in neurological disorders
- (2016) Sebastian A. Lewandowski et al. PHARMACOLOGY & THERAPEUTICS
- Immunology of Multiple Sclerosis
- (2016) Mireia Sospedra et al. SEMINARS IN NEUROLOGY
- Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
- (2015) Sebastian A. Lewandowski et al. ACTA NEUROPATHOLOGICA
- Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration
- (2015) Lucy Liu et al. CELL
- Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
- (2015) Enming J. Su et al. Frontiers in Cellular Neuroscience
- Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier
- (2014) A. Reijerkerk et al. JOURNAL OF IMMUNOLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Pathology and disease mechanisms in different stages of multiple sclerosis
- (2013) Hans Lassmann JOURNAL OF THE NEUROLOGICAL SCIENCES
- Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
- (2013) Milena Z. Adzemovic et al. PLoS One
- Platelet-Derived Growth Factor C Deficiency in C57BL/6 Mice Leads to Abnormal Cerebral Vascularization, Loss of Neuroependymal Integrity, and Ventricular Abnormalities
- (2012) Linda Fredriksson et al. AMERICAN JOURNAL OF PATHOLOGY
- Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method
- (2012) Cécile Arellano et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Imatinib Enhances Functional Outcome after Spinal Cord Injury
- (2012) Mathew B. Abrams et al. PLoS One
- Capture, crawl, cross: the T cell code to breach the blood–brain barriers
- (2012) Britta Engelhardt et al. TRENDS IN IMMUNOLOGY
- Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
- (2011) Friederike Pfeiffer et al. ACTA NEUROPATHOLOGICA
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Links between ApoE, brain cholesterol metabolism, tau and amyloid β-peptide in patients with cognitive impairment
- (2010) Valerio Leoni et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Disruption of central nervous system barriers in multiple sclerosis
- (2010) Jorge Ivan Alvarez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The blood–brain barrier, chemokines and multiple sclerosis
- (2010) David W. Holman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Endothelial IL-1R1 is a critical mediator of EAE pathogenesis
- (2010) Qiming Li et al. BRAIN BEHAVIOR AND IMMUNITY
- Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
- (2010) Ray Chui et al. Journal of Neuroinflammation
- Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis
- (2009) Eve A. Subileau et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
- (2008) Enming J Su et al. NATURE MEDICINE
- The Pathologic Substrate of Magnetic Resonance Alterations in Multiple Sclerosis
- (2008) Hans Lassmann NEUROIMAGING CLINICS OF NORTH AMERICA
- Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation
- (2007) E. East et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation